MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,686,033 | +29.5% | 38,706 | +7.4% | 0.01% | +50.0% |
| Q2 2023 | $1,302,414 | +104.7% | 36,048 | +110.7% | 0.00% | +100.0% |
| Q1 2023 | $636,150 | -64.8% | 17,110 | -57.1% | 0.00% | -50.0% |
| Q4 2022 | $1,806,510 | -63.9% | 39,870 | -44.3% | 0.00% | -60.0% |
| Q3 2022 | $4,999,000 | -0.8% | 71,583 | -4.7% | 0.01% | +25.0% |
| Q2 2022 | $5,040,000 | +67.9% | 75,079 | +105.7% | 0.01% | +166.7% |
| Q1 2022 | $3,001,000 | +413.0% | 36,503 | +815.1% | 0.00% | – |
| Q4 2021 | $585,000 | -41.6% | 3,989 | -70.8% | 0.00% | -100.0% |
| Q1 2019 | $1,001,000 | +475.3% | 13,652 | +233.3% | 0.01% | +450.0% |
| Q4 2018 | $174,000 | +81.2% | 4,096 | +101.8% | 0.00% | +100.0% |
| Q3 2018 | $96,000 | -31.4% | 2,030 | -55.6% | 0.00% | 0.0% |
| Q1 2018 | $140,000 | +150.0% | 4,569 | -4.0% | 0.00% | 0.0% |
| Q3 2017 | $56,000 | +409.1% | 4,759 | +53.5% | 0.00% | – |
| Q2 2017 | $11,000 | -31.2% | 3,100 | 0.0% | 0.00% | – |
| Q1 2017 | $16,000 | -88.1% | 3,100 | -27.2% | 0.00% | -100.0% |
| Q2 2015 | $134,000 | – | 4,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |